
Winter 2022 issue of quarterly NFID eNewsletter covering:
- Fighting Flu, RSV, and COVID-19
- Awards Gala & Silent Auction Highlights
- Partner News
- NFID Holiday Wishes
- More …
Message From Headquarters
As 2022 comes to a close, we encourage you to take a moment to join us and reflect on all that the National Foundation for Infectious Diseases (NFID) has accomplished during the past year, with the help of our many donors and partners. On behalf of NFID, thank you for your ongoing support.
We have accomplished much, but there is still so much more to do, and we cannot do it alone. The US is experiencing a robust influenza (flu) season, along with increased cases of respiratory syncytial virus (RSV) and COVID-19. Vulnerable populations remain unprotected, health disparities persist, and routine vaccination rates have declined across age groups. Although the challenges have been great, together with our partners, NFID has risen to the challenge to help build vaccine confidence, increase immunization rates, and raise awareness about the burden of infectious diseases across the lifespan …
Related Posts

The Double Helix, Winter 2024
Quarterly eNewsletter covering the latest in infectious disease prevention with exclusive partner updates, engaging NFID resources (including webinars, podcasts, and blogs), a reader poll to share your voice, and more …

The Double Helix, Fall 2024
Quarterly eNewsletter covering: Respiratory Disease Prevention This Fall and Winter, Strategies to Improve Adult Immunization, Awards Gala Recap, Clinical Vaccinology Course, NFID Resources (Videos, Webinars, Podcasts, Blogs), and more …

The Double Helix, Summer 2024
Quarterly eNewsletter covering: NFID Spanish Website, Increasing US Vaccine Uptake, Adult Immunization Rates, Bird Flu Updates, Upcoming NFID Events, Resources (Webinars, Podcasts, Blogs), Partner Spotlight, and more …